Previous 10 | Next 10 |
home / stock / shtdf / shtdf news
JP Yim/Getty Images Entertainment The Director-General of the World Health Organization ((WHO)), Dr. Tedros Adhanom Ghebreyesus on Thursday called for a global effort to vaccinate at least 10% of the population of every country by September against COVID-19. In a virtual address to India Glob...
Kevin Frayer/Getty Images News Two Chinese COVID-19 vaccines, including ones made by Sinovac Biotech (SVA) and Sinopharm (SHTDF), are less effective in creating antibodies against the Delta variant compared to other strains, Reuters reports. Feng Zijian, former deputy director of the Chi...
Messenger RNA-based technology that is highly effective in preventing Covid-19 can also be used for treatment of other diseases. High efficacy rates in preventing Covid-19 spark rush by Chinese companies into mRNA vaccines and treatments. At least one Chinese-made mRNA Covid vacci...
China-based Sinopharm Group's (SHTDF) two coronavirus vaccines show more than 70% efficacy against COVID-19, Reuters reports.At least two weeks after the second shot, one of the vaccine developed by Wuhan-based subsidiary showed an efficacy of 72.8% against symptomatic COVID-19, the peer-revi...
The WHO approved Sinopharm's COVID-19 vaccine for emergency use, which will give poorer nations access to a vaccine against the global pandemic. CoronaVac is the first China-developed COVID-19 vaccine under consideration in Europe, joining vaccines from CureVac, Novavax and a Russian ...
On Friday, the World Health Organization ((WHO)) has granted the emergency use authorization for the COVID-19 vaccine developed by Sinopharm Group ([[SHTDF]] +6.6%), making it the first Chinese vaccine to receive its backing.The endorsement given by the WHO technical advisory group will ...
Seychelles with the highest COVID-19 vaccination rate in the world has reimposed COVID-19 restrictions as infections rise, Bloomberg reports.The new social curbs are similar to those that were in force at the end of 2020 and include the measures to close schools and suspend spo...
Sinopharm, China's large state-owned pharma, will transfer six of its vaccine companies to Beijing Tiantan Biological Products, a Shanghai-listed biopharma that is 50% owned by Sinopharm. Shanghai's SciNeuro Pharma in-licensed Greater China rights to Lilly's alpha-synuclein targeted a...
In a very surprising statement, Gao Fu (the head of the Chinese Center for Disease Control and Prevention) said at a conference in Chengdu over the weekend that the protection figures of the Chinese vaccines are "not high". The “Sputnik-V” vaccine from the Gamaleya Insti...
Sinopharm's revenue and net income grew by +7.3% and +14.9% YoY in FY 2020 which was better than expected, but the company's operating cash flow decreased by -40.6% last year. The recent fourth round of China's centralized drug procurement program has similar negative trends as t...
News, Short Squeeze, Breakout and More Instantly...
Sinopharm Group Co. Ltd. Company Name:
SHTDF Stock Symbol:
OTCMKTS Market:
New York City, NY: May 04, 2020 – Published via (Wired Release):- “Market.us presents a new report titled Ammonium Phosphomolybdate Market: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information related to f...